Lorlatinib - Induced pulmonary arterial hypertension

Chabrol, A; Mayenga, M; Hamid, AM; Friard, S; Salvator, H; Doubre, H; Fraboulet, S; Metivier, AC; Catherinot, E; Rivaud, E; Chaumais, MC; Montani, D; Couderc, LJ; Tcherakian, C

Chabrol, A (reprint author), Hop Foch, Serv Pneumol, 40 Rue Worth, F-92150 Suresnes, France.

LUNG CANCER, 2018; 120 (): 60

Abstract

We report here the first cases, to our knowledge, of pulmonary arterial hypertension induced by lorlatinib. It s the first time that a tyrosine kinase......

Full Text Link